RxDoctor Payments Data

Kathyrn Santoro, MD

Obstetrics · Birmingham, ALNPI 1861792913

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 153 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by AbbVie at 32.2% of the total. Reporting peaked in 2021 at $598 and has fallen 81.5% since, to $111 in 2025.

$2,257in general payments, 2019–2025

Across 153 payments — averaging $14.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$727
  • Evofem Biosciences, Inc.$225
  • Hologic Sales And Service, LLC$195
  • Conmed Corporation$107
  • Mayne Pharma Commercial LLC$73
  • Exeltis, USA Inc.$73
  • plus $856 from 28 others

What the payments were for

  • Food & beverage$2,22098%
  • Education$372%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few obstetrics providers in Alabamato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$2,987
Medicare patients
14
Services billed
81

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol70$3,170
Tolterodine Tartrate ErTolterodine Tartrate13$1,971
ProgesteroneProgesterone, Micronized18$1,291
ValacyclovirValacyclovir Hcl15$827

Paid to pharmacies, not to this prescriber.

Other obstetrics in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →